Biosimilar Product Labelling | Medicines for Europe

To view the full paper, please click here.

Policy recommendations on uptake of biosimilar medicines in… 5 November 2021 Policy recommendations on uptake of biosimilar medicines in the retail…
IQVIA - Assessing the Biosimilar Void 30 October 2023 While biosimilar competition in Europe has played a vital role…
Position Paper - Unitary SPC & Unified Mechanism for the… 13 November 2022 Open
EMA/HMA share definitive EU-wide position on biosimilar… 19 September 2022 The Biosimilar medicines group, a Medicines for Europe sector group,…